These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14986822)

  • 1. Hepatic clearance of tissue-type plasminogen activator and plasma kallikrein in experimental liver fibrosis.
    Nagaoka MR; Kouyoumdjian M; Borges DR
    Liver Int; 2003 Dec; 23(6):476-83. PubMed ID: 14986822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hepatic clearance of recombinant tissue-type plasminogen activator decreases after an inflammatory stimulus.
    Nagaoka MR; Kouyoumdjian M; Borges DR
    Braz J Med Biol Res; 2000 Jan; 33(1):119-25. PubMed ID: 10625883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma kallikrein clearance by the liver of chronic carbon tetrachloride-treated rats.
    Toledo CF; Kouyoumdjian M; Lanzoni VP; Borges DR
    J Gastroenterol Hepatol; 1995; 10(2):165-8. PubMed ID: 7787162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma kallikrein clearance by the liver: a review.
    Borges DR; Kouyoumdjian M
    Braz J Med Biol Res; 1994 Aug; 27(8):2033-41. PubMed ID: 7538375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.
    Zhang LP; Takahara T; Yata Y; Furui K; Jin B; Kawada N; Watanabe A
    J Hepatol; 1999 Oct; 31(4):703-11. PubMed ID: 10551395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma kallikrein clearance by the liver in experimental cirrhosis].
    de Toledo CF; Loureiro-Silva MR; Molina HM; Lanzoni VP; Kouyoumdjian M; Borges DR
    Rev Assoc Med Bras (1992); 1995; 41(6):367-72. PubMed ID: 8733244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-allyl-glutathione improves experimental liver fibrosis by regulating Kupffer cell activation in rats.
    Takemura S; Azuma H; Osada-Oka M; Kubo S; Shibata T; Minamiyama Y
    Am J Physiol Gastrointest Liver Physiol; 2018 Feb; 314(2):G150-G163. PubMed ID: 28971836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma kallikrein clearance by the liver of normal and injured rats.
    Toledo CF; Kouyoumdjian M; Borges DR
    Adv Exp Med Biol; 1989; 247B():591-4. PubMed ID: 2610095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma-kallikrein clearance by the liver of acetaminophen-intoxicated rats.
    de Toledo CF; Borges DR
    Life Sci; 1993; 52(17):1451-9. PubMed ID: 8464345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clearance rate of plasma kallikrein by the liver increases during the acute-phase response to inflammation.
    Martins B; Kouyoumdjian M; Limaos EA; Borges DR
    Agents Actions; 1992 Sep; 37(1-2):111-3. PubMed ID: 1456171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium receptors located in fibrotic septa: a new target to reduce portal pressure in liver cirrhosis.
    Sansoè G; Aragno M; Mastrocola R; Paternostro C; Parola M
    Clin Sci (Lond); 2013 Jul; 125(2):67-75. PubMed ID: 23384153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.
    Le Couteur DG; Hickey H; Harvey PJ; Gready J; McLean AJ
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1553-8. PubMed ID: 10336552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of interferon alpha on the rat liver injured by chronic administration of carbon tetrachloride.
    Madro A; Słomka M; Celiński K; Chibowski D; Czechowska G; Kleinrok Z; Karpińska A
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):55-60. PubMed ID: 12898905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intact hepatocyte theory of impaired drug metabolism in experimental cirrhosis in the rat.
    Wood AJ; Villeneuve JP; Branch RA; Rogers LW; Shand DG
    Gastroenterology; 1979 Jun; 76(6):1358-62. PubMed ID: 437433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of exogenous and endogenously generated H2O2 on phagocytic activity and glucose release of normal and cirrhotic livers.
    Petermann H; Lüdicke U; Nothnagel T; Dargel R
    J Hepatol; 1998 Mar; 28(3):461-70. PubMed ID: 9551685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phagocytic function and metabolite production in thioacetamide-induced liver cirrhosis: a comparative study in perfused livers and cultured Kupffer cells.
    Petermann H; Heymann S; Vogl S; Dargel R
    J Hepatol; 1996 Apr; 24(4):468-77. PubMed ID: 8738734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of combined use of vitamin D and puerarin in anti-hepatic fibrosis by regulating the Wnt/β-catenin signalling pathway.
    Huang GR; Wei SJ; Huang YQ; Xing W; Wang LY; Liang LL
    World J Gastroenterol; 2018 Sep; 24(36):4178-4185. PubMed ID: 30271082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of carbon tetrachloride hepatotoxicity by pentosan polysulfate in rats.
    Zim MC; Silveira TR; Schwartsmann G; Cerski T; Motta A
    Braz J Med Biol Res; 2002 Nov; 35(11):1339-46. PubMed ID: 12426634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetylcysteine prevents carbon tetrachloride-induced liver cirrhosis: role of liver transforming growth factor-beta and oxidative stress.
    Galicia-Moreno M; Rodríguez-Rivera A; Reyes-Gordillo K; Segovia J; Shibayama M; Tsutsumi V; Vergara P; Moreno MG; Muriel P
    Eur J Gastroenterol Hepatol; 2009 Aug; 21(8):908-14. PubMed ID: 19398917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of tissue-type plasminogen activator gene in mice aggravated liver fibrosis.
    Hsiao Y; Zou T; Ling CC; Hu H; Tao XM; Song HY
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e258-64. PubMed ID: 17944888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.